Sat, Nov 22, 2014, 9:25 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • aw00108400 aw00108400 Jun 3, 2013 9:37 AM Flag

    Show your face Dr. V

    You own these poor "little guys" an explanation about why you lured them into this disaster with all of your "work" on the science. At least give them an education and admit that you are a hedge fund short player and wanted to get the stock price higher ahead of ASCO so you could short more...that, my friends, is how the street really works...right Dr. V?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Nice call, but I don't base my investing a comments posted on Yahoo message boards.

      Unfortunately with these spec stocks (biopharma especially) things can go very wrong very fast.

      • 1 Reply to syenfrout
      • No one likes to see a cancer trial fail, but to be surprised by this reaction in the stock price is idiotic. Shorts up 2.5 million shares, thestreet pumping it prior to the data and the chief medical president leaving abruptly were all plain signs...I closed my options positions with a juicy gain. I honestly think it goes lower when the combined survival data is disclosed as you will probably not see much of a survival benefit aside from the cherry-picked PR this AM. Of course there was a survival benefit in the arm that moved to GALAXY-2...that's what the trial design called for!

3.18+0.09(+2.91%)Nov 21 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Hexcel Corp.
NYSEFri, Nov 21, 2014 4:02 PM EST
Celgene Corporation
NasdaqGSFri, Nov 21, 2014 4:00 PM EST
BHP Billiton plc
NYSEFri, Nov 21, 2014 4:02 PM EST